| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Web Design > Budgeting a Web Site - Are You Ready to Commit? |
|
Main Subject - Budgeting a Web Site - Are You Ready to Commit?
Too often we see Web sites "under construction," "coming soon" or announcing events that were over long ago. When a site becomes outdated it tells According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product visitors that the site owner is sloppy and unreliable, that there is no reason to look further at the site or to return in the future. Even an ignored site ha ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s a voice. Sometimes companies rush to put a Web site up because their competition has a site or because they believe it's a magic way to increase sales auto lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. matically. They underestimate the time and expense needed to compete in what is becoming a fierce marketplace. Putting up a quick Web site and forgetting it is, at th here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e very least, a waste of money, and at worst, an ongoing negative advertisement. The irony here is that while a good Web site needs to be marketed, a bad site is liabl d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e to pop up and make a company look bad at any time. No commitment phobias allowed ... Maintenance of a Web site after creation is just as important ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc as initial development. Keeping information fresh and up to date is a considerable commitment that cannot be overlooked. A Web site is just one piece of a much large easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi r marketing picture and all the pieces need to be considered during development. So, approach a Web site with the understanding that it is an ongoing job. If nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically you have a limited budget, consider the following:
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ age that lists a date when the site will be completed. It's not necessarily wrong to register a domain and have a temporary page; however, it's much better to ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi put up a single page that gives some useful information to potential visitors while you work on developing the full site. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a
dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod staff and finances. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin l>
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen li> t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ide may influence the appropriateness of a site's contents. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e announced at all. Even with the best of intentions, deadlines can be missed. Whenever possible, do not make announcements about upcoming services, products, y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products or site content that include a deadline date. The easiest way to waste money on a Web site, is to under budget and fail to realize the ongoing requirements . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de necessary to keep the site up to date. Any other efforts such as search engine optimization will also be wasted. Visitors may find the site, may visit it once. But if elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip they find outdated or irrelevant content, the next site is just a click away. If something is too old to use it doesn't get used very much. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:eBook Writing Secrets - 5 Ways To Write Your eBook Now 3 Easy Steps to Improve the Search Engine Ranking of Your Website Flash Intros On Websites - Why It's Time To Ditch The Flash Intro
|